Myopowers Medical Technologies
About:
Myopowers Medical Technologies is focused on the development of artificial muscles for the treatment of severe incontinences.
Website: http://www.myopowers.com
Top Investors: Novartis Venture Fund, Truffle Capital, BlueOcean Ventures, Gran Plasa
Description:
Myopowers Medical Technologies is a French medical device company that develops innovative technologies to provide muscle assistance to patients with high unmet medical needs. The technology can be applied to a number of indications in the GI, cardiology or urology area. The company focus is the development of ARTUS, a new and unique implantable device for the treatment of stress urinary incontinence. Stress urinary incontinence is a condition that affects millions of people around the world. Unfortunately, currently available products are old with significant limitations such as tissue erosion, infection or mechanical failure leading frequent re-operation. ARTUS is made of smooth and flat silicon cuff placed around the urethra. It is individually actionable and adjustable with a remote control allowing patients easy voiding and the surgeon monitoring and adjusting the cuff. This device is the first artificial urinary system specifically designed to include the treatment of female patients who account for a vast majority of the urinary incontinence market.
$21.1M
Less than $1M
Besançon, Franche-Comte, France
2004-01-01
info(AT)myopowers.com
Daniel Hayoz, Piergiorgio Tozzi
11-50
2015-06-16
Private
© 2025 bioDAO.ai